Purpose: Intracranial tumors may cause eye misalignment and interruption of
sensory fusion, The ocular misalignment may be permanent or may be correct
ed after tumor treatment with or without specific strabismus treatment. Thi
s report analyzes the binocular vision outcome of children with misaligned
eyes from brain tumors who regain orthotropia.
Design: A retrospective noncomparative case series.
Participants: Twenty-three surviving children less than 18 years of age wit
h a new heterotropia and absence of fusion associated with the development
of a brain tumor.
Interventions: Tumor resection/radiation/chemotherapy and necessary strabis
mus management.
Main Outcome Measure: Stereopsis (greater than or equal to 4 of 10 circles)
measured with the Randot II stereo test at near fixation.
Results: Fourteen children regained orthotropia either after tumor therapy,
strabismus treatment, or both. Ten of these 14 children with realigned vis
ion regained high-grade stereovision, Nine patients did not regain orthotro
pia and were excluded. The mean age at tumor diagnosis of the fusing group
was 9.9 years (range, 3-17 years) compared with 8.5 years (range, 6-12 year
s) in the four realigned nonfusing patients. The mean duration of misalignm
ent was 12 months (range, 2-51 months) for the fusing group, and 45 months
(range, 14-120 months) for the nonfusing group.
Conclusions: Children and adolescents with brain tumor-associated eye misal
ignment may regain the ability to fuse if their misalignment can be correct
ed. An improved prognosis was noted for those patients when the misalignmen
t had been present for a shorter duration. These data suggest that the outc
ome may be better for incomitant strabismus than that reported for acute co
mitant esotropia. Ophthalmology 2000;107:1880-1883 (C) 2000 by the American
Academy of Ophthalmology.